Article
Careful neuropsychological testing reveals a novel genetic marker, GSTO1*C, linked to the pre-stage of Alzheimer's disease.
Oncotarget - 28 Jun 2016
Umlauf Ellen, Rappold Eduard, Schiller Bettina, Fuchs Petra, Rainer Michael, Wolf Brigitte, Zellner Maria
Abstract excerpt
Approximately 30 million people currently suffer from late-onset Alzheimer's disease (LOAD) worldwide. Twin studies demonstrated that 60 to 80% of LOAD is genetically determined, 20% of which remaining unassigned. This case-control study included 118 cognitively healthy controls, 52 patients with mild cognitive impairment (MCI; the pre-stage of LOAD) and 71 LOAD patients. The participants were genotyped for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.